GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
Status:
Recruiting
Trial end date:
2024-04-04
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of itacitinib in combination
with corticosteroids as first-line treatment for moderate or severe chronic graft-versus-host
disease (cGVHD).